TRPML-1 功能障碍与 IV 型黏脂贮积症中的肾小管病变
该研究通过 21 例 MLIV 患者病历回顾及 MLIV 小鼠、细胞模型,发现 TRPML-1 功能缺失导致近端小管受体介导内吞障碍、肾小管性蛋白尿及炎症纤维化,成年患者出现 2–3 期 CKD,AAV 介导的 TRPML-1 基因递送可逆转小鼠肾脏病理表型。
要点
- MLIV 患者中仅成人被诊断为 2–3 期 CKD,伴 eGFR 降低、BUN/肌酐升高和蛋白尿。
- MLIV 小鼠近端和远端小管出现内溶酶体形态功能改变及自噬受损,近端小管巨蛋白蓄积提示顶端受体介导内吞阻滞。
- AAV 介导的 TRPML-1 基因递送可逆转 MLIV 小鼠关键肾脏病理表型。
核心结论
- TRPML-1 功能障碍与 MLIV 中肾脏疾病的发生相关。
研究设计与样本
- 横断面回顾 21 例 MLIV 患者(年龄 3–43 岁)病历以评估肾功能损害。
- 检查不同年龄 MLIV 小鼠肾脏表型,以及 TRPML-1 沉默的人肾细胞和野生型与 MLIV 小鼠原代小管细胞。
主要发现
- 21 例 MLIV 患者中仅成人被诊断为 2–3 期 CKD,实验室异常包括 eGFR 降低、血 BUN/肌酐升高和蛋白尿。
- MLIV 小鼠近端和远端小管出现内溶酶体形态、功能显著改变及自噬受损。
- 近端小管细胞亚顶端区域巨蛋白(LRP2)蓄积,提示顶端受体介导内吞阻滞。
- 体内外实验证实 MLIV 近端小管细胞液体相内吞减少及 β-乳球蛋白、转铁蛋白和白蛋白等配体摄取受损。
- MLIV 小鼠尿液分析显示肾小管性蛋白尿和酶尿,早期疾病以炎症标志物增加、纤维化和 NF-κB 激活为特征。
临床怎么用
- 对 MLIV 患者应关注肾功能监测,尤其成年患者可能出现 CKD 和肾小管性蛋白尿。
- TRPML-1 基因递送在 MLIV 小鼠中逆转关键肾脏病理表型,提示潜在治疗方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Loss-of-function mutations in the lysosomal channel transient receptor potential cation channel (TRPML-1) cause mucolipidosis type IV (MLIV), a rare lysosomal storage disease characterized by neurological defects, progressive vision loss, and achlorhydria. Recent reports have highlighted kidney disease and kidney failure in patients with MLIV during the second to third decade of life; however, the molecular mechanisms driving kidney dysfunction remain poorly understood. METHODS: A cross-sectional review of medical records from 21 patients with MLIV (ages 3–43 years) was conducted to assess kidney function impairment. In addition, we examined the kidney phenotype of MLIV mice at various ages, along with human kidney cells silenced for TRPML-1 and primary tubular cells from wild-type and MLIV mice. Immunohistology and cell biology approaches were used to phenotype nephron structure, the endolysosomal compartment, and inflammation. Kidney function was assessed through proteomic analysis of mouse urine and in vivo kidney filtration measurements. RESULTS: Of the 21 patients with MLIV, only adults were diagnosed with stage 2–3 CKD. Laboratory abnormalities included lower eGFR and higher levels BUN/creatine in blood and proteinuria. In MLIV mice, we observed significant alterations in endolysosomal morphology, function, and impaired autophagy in proximal and distal tubules. This led to the accumulation of megalin (LRP2) in the subapical region of proximal tubular cells, indicating a block in apical receptor–mediated endocytosis. In vivo and in vitro experiments confirmed reduced fluid-phase endocytosis and impaired uptake of ligands, including β-lactoglobulin, transferrin, and albumin in MLIV proximal tubular cells. Urine analysis revealed tubular proteinuria and enzymuria in mice with MLIV. In addition, early-stage disease was marked by increased inflammatory markers, fibrosis, and activation of the proinflammatory transcription factor NF-κB, coinciding with endolysosomal defects. Importantly, adeno-associated viral–mediated TRPML-1 gene delivery reversed key pathological phenotypes in MLIV mice, underscoring TRPML-1's critical role in kidney function. CONCLUSIONS: Our findings link TRPML-1 dysfunction to the development of kidney disease in MLIV.
引用
- Grieco G, Montefusco S, Nusco E, et al. TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV. J Am Soc Nephrol. 2024. PMID: 40168161. doi:10.1681/ASN.0000000567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。